Dr Dina Fathalla
Teams and roles for Dina Fathalla
Research Associate, Dementia Research Institute
Publication
2023
- Stevenson-Hoare, J. et al. 2023. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease. Brain 146 (2), pp.690-699. (10.1093/brain/awac128)
2022
- Stevenson-Hoare, J. O. et al. 2022. Blood plasma biomarkers improve prediction accuracy over and above genetic predictors of Alzheimer's disease [Abstract]. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 18 (S6) e064192. (10.1002/alz.064192)
2021
- Byrne, R. A. J. et al. 2021. Novel monoclonal antibodies against mouse C1q: characterisation and development of a quantitative ELISA for mouse C1q. Molecular Neurobiology 58 (9), pp.4323-4336. (10.1007/s12035-021-02419-5)
- Fathalla, D. 2021. The generation of antibodies as tools to characterise triggering receptor expressed on Myeloid Cells 2 (TREM2) and explore its role in Alzheimer’s Disease. PhD Thesis , Cardiff University.
2020
- Zelek, W. M. et al. 2020. Cerebrospinal fluid complement system biomarkers in demyelinating disease. Multiple Sclerosis 26 (14), pp.1929-1937. (10.1177/1352458519887905)
- Jackson, H. M. et al., 2020. A novel mouse model expressing human forms for complement receptors CR1 and CR2. BMC Genetics 21 (1) 101. (10.1186/s12863-020-00893-9)
- Ipseiz, N. et al. 2020. Tissue‐resident macrophages actively suppress IL‐1beta release via a reactive prostanoid/IL‐10 pathway. EMBO Journal 39 (14) e103454. (10.15252/embj.2019103454)
- Cipriani, V. et al., 2020. Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration. Nature Communications 11 778. (10.1038/s41467-020-14499-3)
Articles
- Stevenson-Hoare, J. et al. 2023. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease. Brain 146 (2), pp.690-699. (10.1093/brain/awac128)
- Stevenson-Hoare, J. O. et al. 2022. Blood plasma biomarkers improve prediction accuracy over and above genetic predictors of Alzheimer's disease [Abstract]. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 18 (S6) e064192. (10.1002/alz.064192)
- Byrne, R. A. J. et al. 2021. Novel monoclonal antibodies against mouse C1q: characterisation and development of a quantitative ELISA for mouse C1q. Molecular Neurobiology 58 (9), pp.4323-4336. (10.1007/s12035-021-02419-5)
- Zelek, W. M. et al. 2020. Cerebrospinal fluid complement system biomarkers in demyelinating disease. Multiple Sclerosis 26 (14), pp.1929-1937. (10.1177/1352458519887905)
- Jackson, H. M. et al., 2020. A novel mouse model expressing human forms for complement receptors CR1 and CR2. BMC Genetics 21 (1) 101. (10.1186/s12863-020-00893-9)
- Ipseiz, N. et al. 2020. Tissue‐resident macrophages actively suppress IL‐1beta release via a reactive prostanoid/IL‐10 pathway. EMBO Journal 39 (14) e103454. (10.15252/embj.2019103454)
- Cipriani, V. et al., 2020. Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration. Nature Communications 11 778. (10.1038/s41467-020-14499-3)